Medical Journals

Akt/Pkb Regulates Hepatic Metabolism by Directly Inhibiting Pgc-1alpha Transcription Coactivator.

Authors:
  • Li Xinghai
  • Monks Bobby
  • Ge Qingyuan
  • Birnbaum Morris J

From: Institute for Diabetes, Obesity and Metabolism, Cox Institute, University of Pennsylvania School of Medicine and the Howard Hughes Medical Institute, Philadelphia, Pennsylvania 19104, USA.

Nature

  • Publish Date: Jun 2007
  • ISSN: 1476-4687
  • Volume: 447
  • Issue: 7147
  • Pages: 1012-6
  • Medium: Internet
  • Language: English
  • Citation (JAMA): Li Xinghai, Monks Bobby, Ge Qingyuan, et al. Akt/Pkb Regulates Hepatic Metabolism by Directly Inhibiting Pgc-1alpha Transcription Coactivator.. Nature Jun 2007;447:1012-6

Abstract

Type 2 diabetes mellitus, a disease with significant effects on the health and economy of Western societies, involves disturbances in both lipid and carbohydrate metabolism. In the insulin-resistant or diabetic state, the liver is unresponsive to the actions of insulin with regard to the suppression of glucose output but continues to produce large amounts of lipid, the latter mimicking the fed, insulin-replete condition. The disordered distribution of lipids contributes to the cardiovascular disease that is the greatest cause of mortality of type 2 diabetes mellitus. Yet the precise signal transduction pathways by which insulin regulates hepatic lipid synthesis and degradation remain largely unknown. Here we describe a mechanism by which insulin, through the intermediary protein kinase Akt2/protein kinase B (PKB)-beta, elicits the phosphorylation and inhibition of the transcriptional coactivator peroxisome proliferator-activated receptor-coactivator 1alpha (PGC-1alpha), a global regulator of hepatic metabolism during fasting. Phosphorylation prevents the recruitment of PGC-1alpha to the cognate promoters, impairing its ability to promote gluconeogenesis and fatty acid oxidation. These results define a mechanism by which insulin controls lipid catabolism in the liver and suggest a novel site for therapy in type 2 diabetes mellitus.

Mesh Headings (Keywords): Animals, Cell Line, Tumor, Chromatin, Diabetes Mellitus, Type 2, Down-Regulation, Gene Expression Regulation, Glucose, Liver, Mice, Phosphorylation, Phosphoserine, Proto-Oncogene Proteins c-akt, Trans-Activators


Check for Full Text / PubMed Unique Identifier (PMID): 17554339


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.